2013 American Society of Hematology Annual Meeting*

December 7-10, 2013; New Orleans, Louisiana
Jorge E. Cortes, MD, and Michael J. Mauro, MD, review key data on chronic myeloid leukemia from the 2013 American Society of Hematology annual meeting.
Jorge E. Cortes, MD
Michael J. Mauro, MD

Chronic Myeloid Leukemia

In this Expert Analysis, Jorge E. Cortes, MD, and Michael J. Mauro, MD, provide an in-depth review of the most clinically relevant new data presented at the 2013 American Society of Hematology meeting on current and emerging therapies for the treatment of chronic myeloid leukemia.

Jorge E. Cortes, MD Michael J. Mauro, MD Physicians: maximum of 1.5 AMA PRA Category 1 Credits Released: February 21, 2014 Expired: No longer available for credit

Jorge E. Cortes, MD, and Michael J. Mauro, MD, provide expert perspective on the clinical implications of key study findings in chronic myeloid leukemia.

Released: January 13, 2014
Jointly sponsored by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ACHS Logo

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Melissa Velasquez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/

Educational grant provided by:
Celgene Corporation
Genentech BioOncology
Gilead Sciences
Takeda Oncology
Novartis Oncology
Seattle Genetics

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue